 The consensus price target hints at a 60.4 upside potential for Immunocore Holdings PLC Sponsored ADR IMCR. While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 